Kaj Blennow

Kaj Blennow

Queen Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1960 publications

Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers.

Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers.

Journal: Science advances
Published: August 12, 2026

Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy.

Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy.

Journal: JAMA network open
Published: July 13, 2026

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Journal: Neurology
Published: July 13, 2026

Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathology.

Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathology.

Journal: Nature communications
Published: May 01, 2026

Plasma Biomarkers and Clinical Outcomes in Early-Onset Dementia.

Plasma Biomarkers and Clinical Outcomes in Early-Onset Dementia.

Journal: JAMA network open
Published: April 29, 2026

Blood-based multimodal biomarker models for differentiating early-onset Alzheimer's disease from frontotemporal dementia: a longitudinal study of early-onset dementia and family members (LEAF) study.

Blood-based multimodal biomarker models for differentiating early-onset Alzheimer's disease from frontotemporal dementia: a longitudinal study of early-onset dementia and family members (LEAF) study.

Journal: Journal of neurology
Published: April 26, 2026

A Bayesian classification model for differential diagnosis of Alzheimer's disease and frontotemporal dementia using plasma biomarkers.

A Bayesian classification model for differential diagnosis of Alzheimer's disease and frontotemporal dementia using plasma biomarkers.

Journal: Journal of Alzheimer's disease : JAD
Published: April 06, 2026

Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.

Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.

Journal: Communications medicine
Published: April 06, 2026

Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients: The Phase 2 MARBLE Randomized Clinical Trial.

Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients: The Phase 2 MARBLE Randomized Clinical Trial.

Journal: JAMA network open
Published: April 03, 2026

Temporal order of clinical, imaging, and biomarker changes in frontotemporal lobar degeneration-associated syndromes.

Temporal order of clinical, imaging, and biomarker changes in frontotemporal lobar degeneration-associated syndromes.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 25, 2026

Astrocyte reactivity modifies the effects of locus coeruleus norepinephrine-related dysfunction on tau and its impact on cognition.

Astrocyte reactivity modifies the effects of locus coeruleus norepinephrine-related dysfunction on tau and its impact on cognition.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 23, 2026

Effect of 6-week tadalafil treatment on blood-based biomarkers of neurodegeneration: A post-hoc analysis of a randomized controlled trial.

Effect of 6-week tadalafil treatment on blood-based biomarkers of neurodegeneration: A post-hoc analysis of a randomized controlled trial.

Journal: Journal of Alzheimer's disease : JAD
Published: March 13, 2026
Showing 1-12 of 1,960

Last Updated: 09/26/2026